Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to 8-pyrazol-xanthine derivatives, pharmaceutical compositions containing them, and methods of treating conditions and diseases mediated by the adenosine A.sub.2B receptor activity, by employing such compounds.
Accordingly, the present invention provides compounds of
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD
The present invention relates to a method of protecting or delaying retinal neurons from cell death by administering purinergic receptor agonists such as uridine 5'-di-and triphosphates, cytidine 5'-di-and triphosphates, dinucleoside polyphosphates, and their analogs
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD
The present disclosure relates to a series of substituted fused tricyclic compounds, their tautomers, polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of treating conditions and diseases that are
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
TECHNICAL FIELD
This invention relates to treatment of neurodegenerative disorders, and more particularly to Alzheimer's disease and Parkinson's disease.
BACKGROUND
Oxidative stress plays a role in neurodegeneration, regardless of etiology. Physical trauma or secondary effects of insult to the
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
This application is a 371 of PCT/GB99/02924 filed Sep. 3, 1999.
The present invention relates to 4-quinolderivnatives and their use in therapy. In particular, the present invention relates to the treatment of disorders in which the reduction of purinergic neurotransmission could be beneficial. The
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to new inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose) polymerase ["poly(ADP-ribose) polymerase" or "PARP", which is also sometimes called "PARS" for poly(ADP-ribose) synthetase]. More particularly, the invention relates to
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The present invention relates to 4-quinolinylmethanol derivatives and their use in therapy. In particular, the present invention relates to the treatment of disorders in which the reduction of purinergic neurotransmission could be beneficial. The invention relates in particular to adenosine
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF THE INVENTION
The present invention relates to methods and compositions for inhibiting and treating osteoarthritis and for promoting cartilage formation, particularly liposomes and liposomal compositions containing an adenosine receptor agonist, or an analog or derivative thereof or a
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION
This invention relates to novel tricyclic fused pyrimidine derivatives useful as medicines
Pyrazolo[3,4-d]pyrimidine derivatives having, among others, analgesic, antiinflammatory and diuretic actions are disclosed in Japanese Unexamined Patent Publication No. 31694/1978,
O mais completo banco de dados de ervas medicinais apoiado pela ciência
Funciona em 55 idiomas
Curas herbais apoiadas pela ciência
Reconhecimento de ervas por imagem
Mapa GPS interativo - marcar ervas no local (em breve)
Leia publicações científicas relacionadas à sua pesquisa
Pesquise ervas medicinais por seus efeitos
Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes
Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada. * Todas as informações são baseadas em pesquisas científicas publicadas